Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case

Central nervous system (CNS) involvement in multiple myeloma (MM) is a rare and challenging complication associated with poor prognosis and limited treatment options. Emerging T-cell directing therapies, such as bispecific antibodies (bsAbs) and chimeric antigen receptor T cells (CAR-T), have shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutlu, Yasa Gul, Yıgıt Kaya, Sureyya, Maral, Senem, Melek, Elif, Baslar, Zafer, Kaynar, Leylagul, Sevindik, Omur Gokmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611496/
https://www.ncbi.nlm.nih.gov/pubmed/37901215
http://dx.doi.org/10.3389/fimmu.2023.1276295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611496/
https://www.ncbi.nlm.nih.gov/pubmed/37901215
http://dx.doi.org/10.3389/fimmu.2023.1276295

Ejemplares similares